FDA Approved: SUPPRELIN LA — Original Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved SUPPRELIN LA (histrelin acetate) from Endo USA, Inc. under an Original NDA (NDA 022058).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Precocious Puberty

Drugs mentioned

• SUPPRELIN LA (HISTRELIN ACETATE)

Snippet

ORIG AP for SUPPRELIN LA (HISTRELIN ACETATE)